Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The opioid receptors are among the most highly studied members of the superfamily of G-protein coupled receptors. Morphine and endogenous mu opioid peptides exert their pharmacological actions mainly through the
mu opioid receptor
(
MOR
). Expression of opioid receptor proteins is controlled by extensive transcriptional and post-transcriptional processing. Previously, the 5'-untranslated region (UTR) of the mouse
MOR
was found to be important for post-transcriptional regulation of the
MOR
gene in neuronal cells. Here, we demonstrate for the first time the role of vimentin as a post-transcriptional repressor in
MOR
gene regulation. To identify potential regulators of the mouse
MOR
gene, we performed affinity column chromatography using 5'-UTR-specific RNA oligonucleotides using
neuroblastoma
NS20Y cells. Chromatography was followed by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. We identified an intermediate filament protein, vimentin, which bound specifically to the region between -175 and -150 (175-150) of the
MOR
5'-UTR. Binding was confirmed by western blot analysis and RNA supershift assay. Furthermore, a cotransfection study demonstrated that the presence of vimentin resulted in reduced expression of the mouse
MOR
. Our data suggest that vimentin functions as a repressor of
MOR
translation, dependent on 175-150 of the
MOR
5'-UTR.
...
PMID:Vimentin interacts with the 5'-untranslated region of mouse mu opioid receptor (MOR) and is required for post-transcriptional regulation. 2335 76
<< Previous
1
2
3